PLK1-mediated PDHA1 phosphorylation drives mitochondrial dysfunction, mitophagy, and cancer progression in Cr(VI)-associated lung cancer
Journal of Biological Chemistry · 2025
DOI: 10.1016/j.jbc.2025.110406 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025. Verfasst von Qiongsi Zhang und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, Kentucky, USA. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins, Protein Serine-Threonine Kinases, Mitophagy, Cell Cycle Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, US Department of Defense.
Abstract (Originalsprache)
Hexavalent chromium (Cr(VI)) is a class I environmental carcinogen that induces lung epithelial cell transformation and promotes lung cancer progression by altering cell cycle regulation and cellular energy metabolism. In this study, we investigated the role of polo-like kinase 1 (PLK1) in Cr(VI)-transformed (CrT) bronchial epithelial cells (BEAS-2B) and found that PLK1 expression was significantly upregulated in these cells, leading to impaired mitochondrial function and enhanced mitophagy, which in turn stimulated cell proliferation both in vitro and in vivo. Mechanistically, we demonstrated that PLK1 directly phosphorylates the pyruvate dehydrogenase E1 subunit alpha 1 (PDHA1) at Thr57, leading to its destabilization and disruption of pyruvate dehydrogenase complex (PDHc) integrity. This modification inhibits oxidative phosphorylation (OXPHOS) and induces mitochondrial dysfunction. Furthermore, mitochondrial dysfunction triggers mitophagy and accelerates PDHA1 degradation, establishing a positive feedback loop that amplifies mitochondrial impairment and mitophagy, ultimately promoting cancer cell proliferation. These findings underscore the pivotal role of PLK1 in Cr(VI)-associated cancer progression and offer new insights into potential therapeutic targets to inhibit Cr(VI)-induced tumorigenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, Kentucky, USA.
- Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, Kentucky, USA; Markey Cancer Center, University of Kentucky, Lexington, Kentucky, USA.
- Markey Cancer Center, University of Kentucky, Lexington, Kentucky, USA; Department of Pathology and Laboratory Medicine, University of Kentucky, Lexington, Kentucky, USA.
- Department of Chemical and Materials Engineering, University of Kentucky, Lexington, Kentucky, USA.
- Markey Cancer Center, University of Kentucky, Lexington, Kentucky, USA; Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, Kentucky, USA.
- Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, Kentucky, USA; Markey Cancer Center, University of Kentucky, Lexington, Kentucky, USA. Electronic address: Xiaoqi.Liu@uky.edu.
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- US Department of Defense
- Markey Cancer Center, University of Kentucky
- NIH National Institute of General Medical Sciences
- National Institutes of Health
Zitieren
APA
Zhang, Q., Peng, J., Li, Z., Rao, X., Allison, D. B., Qiao, Q., Zhang, Z., Kong, Y., Zhang, Y., Wang, R., Liu, J., Wang, X., Li, C., Mao, F., Shao, Q., Gao, T., & Liu, X. (2025). PLK1-mediated PDHA1 phosphorylation drives mitochondrial dysfunction, mitophagy, and cancer progression in Cr(VI)-associated lung cancer. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2025.110406
Vancouver
Zhang Q, Peng J, Li Z, Rao X, Allison DB, Qiao Q, et al. PLK1-mediated PDHA1 phosphorylation drives mitochondrial dysfunction, mitophagy, and cancer progression in Cr(VI)-associated lung cancer. Journal of Biological Chemistry. 2025. doi:10.1016/j.jbc.2025.110406
BibTeX
@article{Zhang2025,
author = {Zhang, Qiongsi and Peng, Jia and Li, Zhiguo and Rao, Xiongjian and Allison, Derek B and Qiao, Qi and Zhang, Zhuangzhuang and Kong, Yifan and Zhang, Yanquan and Wang, Ruixin and Liu, Jinghui and Wang, Xinyi and Li, Chaohao and Mao, Fengyi and Shao, Qing and Gao, Tianyan and Liu, Xiaoqi},
title = {PLK1-mediated PDHA1 phosphorylation drives mitochondrial dysfunction, mitophagy, and cancer progression in Cr(VI)-associated lung cancer},
journal = {Journal of Biological Chemistry},
year = {2025},
doi = {10.1016/j.jbc.2025.110406}
}
EUVIMED